Division of Basic Science and Translational Research, Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA.
Biological Models Laboratory, Department of Biochemistry and Molecular Biology, College of Medicine, University of the Philippines Manila, Manila, Philippines.
FASEB J. 2022 Oct;36(10):e22551. doi: 10.1096/fj.202200872R.
Genital mycoplasmas can break the cervical barrier and cause intraamniotic infection and preterm birth. This study developed a six-chamber vagina-cervix-decidua-organ-on-a-chip (VCD-OOC) that recapitulates the female reproductive tract during pregnancy with culture chambers populated by vaginal epithelial cells, cervical epithelial and stromal cells, and decidual cells. Cells cultured in VCD-OOC were characterized by morphology and immunostaining for cell-specific markers. We transferred the media from the decidual cell chamber of the VCD-OOC to decidual cell chamber in feto-maternal interface organ-on-a-chip (FMi-OOC), which contains the fetal membrane layers. An ascending Ureaplasma parvum infection was created in VCD-OOC. U. parvum was monitored for 48 h post-infection with their cytotoxicity (LDH assay) and inflammatory effects (multiplex cytokine assay) in the cells tested. An ascending U. parvum infection model of PTB was developed using CD-1 mice. The cell morphology and expression of cell-specific markers in the VCD-OOC mimicked those seen in lower genital tract tissues. U. parvum reached the cervical epithelial cells and decidua within 48 h and did not cause cell death in VCD-OOC or FMi-OOC cells. U. parvum infection promoted minimal inflammation, while the combination of U. parvum and LPS promoted massive inflammation in the VCD-OOC and FMi-OOC cells. In the animal model, U. parvum vaginal inoculation of low-dose U. parvum did not result in PTB, and even a high dose had only some effects on PTB (20%). However, intra-amniotic injection of U. parvum resulted in 67% PTB. We report the colonization of U. parvum in various cell types; however, inconsistent, and low-grade inflammation across multiple cell types suggests poor immunogenicity induced by U. parvum.
生殖道支原体可以破坏宫颈屏障,引起羊膜腔内感染和早产。本研究开发了一种六室阴道-宫颈-蜕膜器官芯片(VCD-OOC),该芯片在培养室内培养阴道上皮细胞、宫颈上皮和基质细胞以及蜕膜细胞,从而模拟妊娠期间的女性生殖道。VCD-OOC 培养的细胞通过形态学和细胞特异性标志物的免疫染色进行鉴定。我们将 VCD-OOC 的蜕膜细胞室中的培养基转移到含有胎儿膜层的胎儿-母体界面器官芯片(FMi-OOC)的蜕膜细胞室中。在 VCD-OOC 中建立了上行解脲支原体感染模型。在感染后 48 小时内,通过乳酸脱氢酶(LDH)测定法监测 U. parvum 的细胞毒性,通过多重细胞因子测定法监测 U. parvum 的炎症效应。使用 CD-1 小鼠建立了上行 U. parvum 感染早产模型。VCD-OOC 中的细胞形态和细胞特异性标志物的表达与下生殖道组织中观察到的相似。在 48 小时内,U. parvum 到达宫颈上皮细胞和蜕膜,并且不会引起 VCD-OOC 或 FMi-OOC 细胞死亡。U. parvum 感染仅在 VCD-OOC 和 FMi-OOC 细胞中引起轻微的炎症,而 U. parvum 与 LPS 的组合则促进了大量炎症。在动物模型中,低剂量 U. parvum 的阴道接种不会导致早产,甚至高剂量也仅对早产有一定作用(20%)。然而,羊膜腔内注射 U. parvum 会导致 67%的早产。我们报道了 U. parvum 在各种细胞类型中的定植;然而,多种细胞类型中的炎症不一致且呈低度,表明 U. parvum 诱导的免疫原性较差。